2/24/2010-Shares of Salix Pharmaceuticals (NASDAQ:SLXP) are trading 21.2% higher to $29.40 Wednesday after the maker of gastrointestinal disease treatments said it won the backing of a U.S. panel to expand the use of its biggest medicine, Xifaxan, over concerns from regulators that the drug wasn't tested adequately.
Link to this comment:
All Comments (0)